Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;39(2):140-3.

Prevalence of lymph node metastasis in radical prostatectomy; a retrospective and multicenter study in iran

Mohsen Ayati  1 , Mohammad Reza Nowroozi  1 , Hassan Jamshidian  1 , Elnaz Ayati  1 , Farhad Zarghan  1
Affiliations

Prevalence of lymph node metastasis in radical prostatectomy; a retrospective and multicenter study in iran

Mohsen Ayati et al. Iran J Med Sci. 2014 Mar.

Abstract

Lymph node (LN) metastasis is considered an important prognostic factor in patients with prostate cancer. The aim of this study was to determine the rate of LN metastasis among an Iranian population who underwent radical prostatectomy (RP) with pelvic LN dissection (PLND). In a retrospective review of medical records, 450 RP cases were included and the data on LN metastasis were extracted from surgical pathology reports. Overall, 4.7% of the patients had LN metastasis. The rate of surgical stage T3 (50% vs. 13.5%; P=0.021) and pathological Gleason score ³7 (82.4% vs. 48.8%; P=0.002) was significantly higher among LN-positive patients. All patients with LN metastasis had a serum prostate specific antigen level >4 ng/ml. The diagnosis of prostate cancer is in an acceptable, but not ideal, stage of the disease; this may be due to screening examinations and tests.

Keywords: Lymph node dissection; Prostate cancer; Prostatectomy.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi: 10.3322/caac.20107. PubMed PMID: 21296855. - PubMed
    1. Mendenhall WM, Nichols RC, Henderson R, Mendenhall NP. Is radical prostatectomy the “gold standard” for localized prostate cancer? Am J Clin Oncol. 2010;33:511–5. doi: 10.1097/COC.0b013e3181b4af05. PubMed PMID: 20010078. - PubMed
    1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59:61–71. doi: 10.1016/j.eururo.2010.10.039. PubMed PMID: 21056534. - PubMed
    1. Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009;55:1251–65. doi: 10.1016/j.eururo.2009.03.012. PubMed PMID: 19297079. - PubMed
    1. Siemens DR. Why all prostate cancer surgery should include an adequate lymph node dissection. Can Urol Assoc J. 2010;4:427–9. doi: 10.5489/cuaj.10185. PubMed PMID: 21191508. - PMC - PubMed

LinkOut - more resources